A Retrospective Analysis of the Effects of Red Light Therapy on Body Contouring

NCT02867150 | Completed Results DMC

• 1 other identifier: MLS-1510
• Study Type: interventional
• Target: 58
• Locations: 0 countries
• Sites: N/A

Brief Summary

The purpose of this study is to determine whether red light therapy using LED 635nm red light for body contouring of the waist, hips and thighs is as effective as red light therapy using Laser 635nm red light.

Conditions

Obesity

Outcome Measures

Primary Outcomes (1)

• Fat Reduction in Treatment Zone as Measured in Inches Lost

  Circumferential measurement of thighs, hips and waist before and after treatment.

  Single 32-minute treatment session

Study Arms (1)

Active Device

EXPERIMENTAL

Active Device: Ward Photonics Photonica Professional Red light therapy system Intervention: Device: Ward Photonics Photonica Professional

Device: Ward Photonics Photonica Professional

Interventions

Ward Photonics Photonica Professional DEVICE

Active Device: Ward Photonics, Photonica Professional Red light therapy system UltraSlim Cold Light® is the name of a patented treatment regimen using the Photonica Professional device for fat removal using LED red light therapy.

Active Device

Eligibility Criteria

• Age: 18 Years - 74 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years or older.
• Male or female.
• Generally good health.

You may not qualify if:

• Pregnancy.
• Active cancer within the past year.
• Diminished ability to void waste (liver or kidneys).
• Photosensitive condition or medication.

Sponsors & Collaborators

• Ward Photonics LLC: lead

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

Overweight; Overnutrition; Nutrition Disorders; Nutritional and Metabolic Diseases; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Results Point of Contact

• Title: Dr. Ellyn Levine M.D.
• Organization: Optimal Health and Weight Center

dr.levine@teamtsfl.com

(619) 567-6914

Study Officials

• Terry J Ward, M.H.A.

  Managing Director

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 3, 2016
• First Posted: August 15, 2016
• Study Start: October 1, 2015
• Primary Completion: October 1, 2015
• Study Completion: October 1, 2015
• Last Updated: June 23, 2017
• Results First Posted: June 23, 2017

Record last verified: 2017-06

Data Sharing

• IPD Sharing: Will not share